Inhibition of triosephosphate isomerase from Trypanosoma brucei with cyclic hexapeptides. 1992

D A Kuntz, and R Osowski, and M Schudok, and R K Wierenga, and K Müller, and H Kessler, and F R Opperdoes
Research Unit for Tropical Diseases, International Institute of Molecular Pathology, Brussels, Belgium.

Two series of oligopeptides have been synthesized. Their effects on the activity of purified triosephosphate isomerase from Trypanosoma brucei and various other organisms have been studied. Using detailed three-dimensional structure information, the first series consisted of both cyclic and linear hydrophilic peptides that were designed to mimic the beta turns of the subunit interface loops of the trypanosome triosephosphate isomerase dimer. None of these exerted any inhibitory effect. The second series consisted of more hydrophobic cyclic peptides, originally designed to inhibit a hepatic transport system. Several of these were very effective in inhibiting the trypanosome triosephosphate isomerase, but not the homologous enzymes from rabbit, dog, yeast or Escherichia coli. The most active peptide, cyclo[-Trp-Phe-D-Pro-Phe-Phe-Lys(Z)-], exerted 50% inhibitory activity at a concentration of 3 microM. The nature of the inhibitory action of one of these compounds cyclo[-Trp-Tyr(OSO3Na)-D-Pro-Phe-Thr(OSO3Na)-Lys(Z)-] was studied in more detail. Its inhibition was noncompetitive and reversible and more than one peptide was able to bind/active site.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

D A Kuntz, and R Osowski, and M Schudok, and R K Wierenga, and K Müller, and H Kessler, and F R Opperdoes
September 1984, Journal of molecular biology,
D A Kuntz, and R Osowski, and M Schudok, and R K Wierenga, and K Müller, and H Kessler, and F R Opperdoes
September 1993, Biochemical and biophysical research communications,
D A Kuntz, and R Osowski, and M Schudok, and R K Wierenga, and K Müller, and H Kessler, and F R Opperdoes
November 1987, Journal of molecular biology,
D A Kuntz, and R Osowski, and M Schudok, and R K Wierenga, and K Müller, and H Kessler, and F R Opperdoes
July 2001, The Biochemical journal,
D A Kuntz, and R Osowski, and M Schudok, and R K Wierenga, and K Müller, and H Kessler, and F R Opperdoes
May 2010, Molecular and biochemical parasitology,
D A Kuntz, and R Osowski, and M Schudok, and R K Wierenga, and K Müller, and H Kessler, and F R Opperdoes
November 2017, Molecules (Basel, Switzerland),
D A Kuntz, and R Osowski, and M Schudok, and R K Wierenga, and K Müller, and H Kessler, and F R Opperdoes
May 1998, European journal of biochemistry,
D A Kuntz, and R Osowski, and M Schudok, and R K Wierenga, and K Müller, and H Kessler, and F R Opperdoes
March 2001, Biochemistry,
D A Kuntz, and R Osowski, and M Schudok, and R K Wierenga, and K Müller, and H Kessler, and F R Opperdoes
June 1986, The EMBO journal,
D A Kuntz, and R Osowski, and M Schudok, and R K Wierenga, and K Müller, and H Kessler, and F R Opperdoes
October 2007, The protein journal,
Copied contents to your clipboard!